Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5941 | 1555 | 31.7 | 44% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
553 | 3 | BRASSINOSTEROIDS//NA K ATPASE//OUABAIN | 17999 |
1104 | 2 | NA K ATPASE//OUABAIN//DIGOXIN | 9793 |
5941 | 1 | DIGOXIN//SERUM DIGOXIN CONCENTRATION//DIGITALIS | 1555 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIGOXIN | authKW | 773476 | 13% | 19% | 204 |
2 | SERUM DIGOXIN CONCENTRATION | authKW | 117811 | 0% | 100% | 6 |
3 | DIGITALIS | authKW | 44597 | 1% | 11% | 21 |
4 | DIGITALIS GLYCOSIDES THERAPEUTIC USE | authKW | 39270 | 0% | 100% | 2 |
5 | HEART FAILURE DRUG THERAPY MORTALITY PHYSIOPATHOLOGY | authKW | 39270 | 0% | 100% | 2 |
6 | METILDIGOXIN | authKW | 39270 | 0% | 100% | 2 |
7 | EUBACTERIUM LENTUM | authKW | 35341 | 0% | 60% | 3 |
8 | BETA METHYLDIGOXIN | authKW | 29450 | 0% | 50% | 3 |
9 | DIGITOXIN | authKW | 28098 | 1% | 11% | 13 |
10 | DIGOXIN CLEARANCE | authKW | 26179 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 8721 | 44% | 0% | 685 |
2 | Cardiac & Cardiovascular System | 5319 | 24% | 0% | 368 |
3 | Medicine, General & Internal | 2533 | 20% | 0% | 306 |
4 | Geriatrics & Gerontology | 429 | 3% | 0% | 48 |
5 | Peripheral Vascular Diseases | 114 | 3% | 0% | 51 |
6 | Toxicology | 113 | 3% | 0% | 52 |
7 | Medical Laboratory Technology | 84 | 1% | 0% | 23 |
8 | Gerontology | 69 | 1% | 0% | 16 |
9 | Chemistry, Medicinal | 48 | 2% | 0% | 38 |
10 | Medicine, Research & Experimental | 38 | 3% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTI INFECT CLIN DEV | 19635 | 0% | 100% | 1 |
2 | BD BIOSCIE DISCOVERY WARE | 19635 | 0% | 100% | 1 |
3 | BIRMINGHAM ATLANTA GERATR EDUC CLIN | 19635 | 0% | 100% | 1 |
4 | BUR 2165 | 19635 | 0% | 100% | 1 |
5 | CARDIAC CATHETERIZAT 111A2 | 19635 | 0% | 100% | 1 |
6 | CARDIOL 736 CAMBRIDGE ST | 19635 | 0% | 100% | 1 |
7 | CARDIOPEDIAT SERV | 19635 | 0% | 100% | 1 |
8 | CARDIOVASC EPIDEMIOL OUTCOMES | 19635 | 0% | 100% | 1 |
9 | DRUG INTERACT DATABASE PROGRAM | 19635 | 0% | 100% | 1 |
10 | DSAR DRUG DISPOSIT FF | 19635 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 13312 | 4% | 1% | 63 |
2 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 10265 | 4% | 1% | 61 |
3 | PEDIATRIC PHARMACOLOGY | 7005 | 1% | 4% | 8 |
4 | JOURNAL OF CLINICAL PHARMACOLOGY | 6941 | 3% | 1% | 44 |
5 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 4798 | 2% | 1% | 31 |
6 | HERZ KREISLAUF | 3378 | 1% | 1% | 13 |
7 | ACTA MEDICA SCANDINAVICA | 3033 | 1% | 1% | 18 |
8 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 2969 | 1% | 1% | 13 |
9 | CARDIOVASCULAR DRUGS AND THERAPY | 2567 | 1% | 1% | 16 |
10 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2477 | 3% | 0% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIGOXIN | 773476 | 13% | 19% | 204 | Search DIGOXIN | Search DIGOXIN |
2 | SERUM DIGOXIN CONCENTRATION | 117811 | 0% | 100% | 6 | Search SERUM+DIGOXIN+CONCENTRATION | Search SERUM+DIGOXIN+CONCENTRATION |
3 | DIGITALIS | 44597 | 1% | 11% | 21 | Search DIGITALIS | Search DIGITALIS |
4 | DIGITALIS GLYCOSIDES THERAPEUTIC USE | 39270 | 0% | 100% | 2 | Search DIGITALIS+GLYCOSIDES+THERAPEUTIC+USE | Search DIGITALIS+GLYCOSIDES+THERAPEUTIC+USE |
5 | HEART FAILURE DRUG THERAPY MORTALITY PHYSIOPATHOLOGY | 39270 | 0% | 100% | 2 | Search HEART+FAILURE+DRUG+THERAPY+MORTALITY+PHYSIOPATHOLOGY | Search HEART+FAILURE+DRUG+THERAPY+MORTALITY+PHYSIOPATHOLOGY |
6 | METILDIGOXIN | 39270 | 0% | 100% | 2 | Search METILDIGOXIN | Search METILDIGOXIN |
7 | EUBACTERIUM LENTUM | 35341 | 0% | 60% | 3 | Search EUBACTERIUM+LENTUM | Search EUBACTERIUM+LENTUM |
8 | BETA METHYLDIGOXIN | 29450 | 0% | 50% | 3 | Search BETA+METHYLDIGOXIN | Search BETA+METHYLDIGOXIN |
9 | DIGITOXIN | 28098 | 1% | 11% | 13 | Search DIGITOXIN | Search DIGITOXIN |
10 | DIGOXIN CLEARANCE | 26179 | 0% | 67% | 2 | Search DIGOXIN+CLEARANCE | Search DIGOXIN+CLEARANCE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZIFF, OJ , LANE, DA , SAMRA, M , GRIFFITH, M , KIRCHHOF, P , LIP, GYH , STEEDS, RP , TOWNEND, J , KOTECHA, D , (2015) SAFETY AND EFFICACY OF DIGOXIN: SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL AND CONTROLLED TRIAL DATA.BMJ-BRITISH MEDICAL JOURNAL. VOL. 351. ISSUE . P. - | 52 | 58% | 19 |
2 | RODIN, SM , JOHNSON, BF , (1988) PHARMACOKINETIC INTERACTIONS WITH DIGOXIN.CLINICAL PHARMACOKINETICS. VOL. 15. ISSUE 4. P. 227-244 | 90 | 83% | 84 |
3 | VAMOS, M , ERATH, JW , HOHNLOSER, SH , (2015) DIGOXIN-ASSOCIATED MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE LITERATURE.EUROPEAN HEART JOURNAL. VOL. 36. ISSUE 28. P. 1831 -1838 | 25 | 63% | 31 |
4 | HOOD, WB , DANS, AL , GUYATT, GH , JAESCHKE, R , MCMURRAY, JJV , (2014) DIGITALIS FOR TREATMENT OF HEART FAILURE IN PATIENTS IN SINUS RHYTHM.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 38 | 56% | 3 |
5 | CHEN, Y , CAI, XY , HUANG, WJ , WU, YX , HUANG, YL , HU, YZ , (2015) INCREASED ALL-CAUSE MORTALITY ASSOCIATED WITH DIGOXIN THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AN UPDATED META-ANALYSIS.MEDICINE. VOL. 94. ISSUE 52. P. - | 25 | 81% | 3 |
6 | AMBROSY, AP , BUTLER, J , AHMED, A , VADUGANATHAN, M , VAN VELDHUISEN, DJ , COLUCCI, WS , GHEORGHIADE, M , (2014) THE USE OF DIGOXIN IN PATIENTS WITH WORSENING CHRONIC HEART FAILURE RECONSIDERING AN OLD DRUG TO REDUCE HOSPITAL ADMISSIONS.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 63. ISSUE 18. P. 1823 -1832 | 32 | 57% | 13 |
7 | HOOYMANS, PM , MERKUS, FWHM , (1985) CURRENT STATUS OF CARDIAC GLYCOSIDE DRUG-INTERACTIONS.CLINICAL PHARMACY. VOL. 4. ISSUE 4. P. 404-413 | 67 | 85% | 12 |
8 | ZIFF, OJ , KOTECHA, D , (2016) DIGOXIN: THE GOOD AND THE BAD.TRENDS IN CARDIOVASCULAR MEDICINE. VOL. 26. ISSUE 7. P. 585 -595 | 32 | 58% | 0 |
9 | MARCUS, FI , (1985) PHARMACOKINETIC INTERACTIONS BETWEEN DIGOXIN AND OTHER DRUGS.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 5. ISSUE 5. P. A82-A90 | 55 | 89% | 53 |
10 | EICHHORN, EJ , GHEORGHIADE, M , (2002) DIGOXIN.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 44. ISSUE 4. P. 251 -266 | 37 | 62% | 66 |
Classes with closest relation at Level 1 |